A Chemical Biology Approach to Developing STAT Inhibitors: Molecular Strategies for Accelerating Clinical Translation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Chemical Biology Approach to Developing STAT Inhibitors: Molecular Strategies for Accelerating Clinical Translation

Published:2011-06-15 Issue:6 Volume:2 Page:518-524
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Nelson Erik A.¹,Sharma Sreenath V.²³,Settleman Jeffrey²,Frank David A.¹

Affiliation:

1. Department of Medical Oncology, Dana-Farber Cancer Institute, Departments of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02215

2. Massachusetts General Hospital, Harvard Medical School

3. Current address: Oncology Drug Discovery, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation;Cancers;2024-03-31

2. Dual inhibition of STAT3 and STAT5 may overcome imatinib resistance in chronic myeloid leukemia;Hematology;2023-06-22

3. Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition;International Journal of Molecular Sciences;2023-03-01

4. The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer;Current Cancer Drug Targets;2022-03

5. The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase;Journal of Biological Chemistry;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP